Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  EntreMed Inc    ENMD   US29382F2020

ENTREMED INC

 (ENMD)
0
 SummaryQuotesChart AnalysisNewsForum 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/20/2013 05/21/2013 05/22/2013 05/23/2013 05/24/2013 Date
1.85(c) 1.83(c) 1.8(c) 1.78(c) 1.77(c) Last
31 066 18 178 12 232 22 939 28 518 Volume
0.00% -1.08% -1.64% -1.11% -0.56% Change
More quotes
Company
Sector
Calendar
05/30 | 10:00amShareholder meeting
More about the company
Chart ENTREMED INC
Duration : Period :
EntreMed Inc Technical Analysis Chart | ENMD | US29382F2020 | 4-Traders
Full-screen chart
Latest news on ENTREMED INC
05/06 ENTREMED INC: Patent Issued In China For EntreMed’s Lead Drug Candidate ENMD-20..
05/03 ENTREMED INC: Patent Issued In U.S. For EntreMed’s 2ME2 In Rheumatoid Diseases
04/05 ENTREMED INC: EntreMed Announces Changes to Board of Directors and CEO Appointm..
03/21 ENTREMED INC: EntreMed Reports Fourth Quarter And Year-End 2012 Financial Resul..
03/01 ENTREMED, INC.: EntreMed to Raise $10.7 Million in Registered Direct Offering
01/23 ENTREMED, INC.: EntreMed Announces Initiation Of Phase 2 Trial In Advanced/Meta..
01/07 ENTREMED, INC.: EntreMed Files New Drug Clinical Trial Application For ENMD-207..
2012 ENTREMED, INC.: PNAS Publishes Preclinical Results of EntreMed’s 2ME2 for Multi..
2012 ENTREMED, INC.: EntreMed Announces Publication Of Preclinical Results For ENMD-..
2012 ENTREMED, INC.: EntreMed Reports Third Quarter 2012 Financial Results
2012 ENTREMED, INC.: EntreMed Announces Initiation Of Phase 2 Trial In Triple-negati..
2012 ENTREMED, INC.: EntreMed Initiates Plans for China Office
More news
Forum ENTREMED INC
Be the first to post a message on ENTREMED INC
Advertisement
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.